$46M sweet spot round size
Most of their 5 investments are in rounds between $10M and $64M
2014
Eidos Therapeutics raised $64M on April 5, 2018
Investors: Aisling Capital, Viking Global Investors, RA Capital Management, L.P., Perceptive Advisors and BridgeBio
QED Therapeutics raised $65M on January 30, 2018
Investors: BridgeBio
PellePharm raised $20M on August 1, 2017
Investors: BridgeBio
MyoKardia raised $46M on April 30, 2015
Investors: Casdin Capital, LLC, Cowen Inc. and BridgeBio
MyoKardia raised $10M on August 22, 2014
Investors: Third Rock Ventures, Cowen Inc., Casdin Capital, LLC and BridgeBio
$299M
from 14 investors over 14 rounds
BridgeBio raised $250M on September 22, 2023
Investors: Qatar Investment Authority
BridgeBio raised $299M on January 23, 2019
Investors: Aisling Capital, Hercules Capital, Inc., Perceptive Advisors, Viking Global Investors, KKR & Co. Inc. and Cormorant Capital
BridgeBio raised $135M on September 13, 2017
Investors: Aisling Capital, Perceptive Advisors, Viking Global Investors, Cormorant Capital and KKR & Co. Inc.
BridgeBio raised $33M on May 1, 2017
Investors: KKR & Co. Inc.
BridgeBio raised $6.9M on March 1, 2016
Investors: KKR & Co. Inc.